Speaker illustration

Doctor Thomas Adam Agbaedeng

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Dr Agbaedeng is postdoctoral fellow at the Centre for Heart Rhythm Disorders, The University of Adelaide. Dr Agbaedeng has a broad research interest in drivers of cardiac fibrillation and arrhythmias. He pursues a mechanistic line of research, which incorporates animal models, ex vivo models, molecular biology techniques, biochemical, and histological methods to decipher factors contributing to abnormal cardiac remodelling.

Fibrosis detected by late-gadolinium enhancement cardiac MRI is associated with atrial fibrillation and poorer ablation outcome: A meta-analysis

Event: ESC Congress 2019

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: Epidemiology of atrial fibrillation


Weight fluctuation demonstrates residual atrial arrhythmogenic substrate despite final weight loss in a chronic sheep model: implications for epicardial fat and fibrofatty infiltrates

Event: ESC Congress 2019

Topic: Arrhythmias

Session: Insight into atrial physiology and pathology


Ventricular structural remodelling in an ovine sheep model of sustained weight gain: Potential role of desmoglein-2 in fibro-fatty replacement and arrhythmogenicity

Event: EHRA 2018

Topic: Ventricular Arrhythmias and SCD - Pathophysiology and Mechanisms

Session: Young Investigator Awards - Basic Science


Risk of sudden cardiac death in obesity: A systematic review and meta-analysis of emerging evidence

Event: ESC Congress 2017

Topic: Risk scores

Session: Lipids, obesity and metabolic syndrome


Effects of epicardial fat and anterior fat pad removal on post-operative atrial fibrillation: a systematic review and meta-analysis

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb